老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Allogene Therapeutics Inc.

1.78
0.0000
盤前：1.810.0300+1.69%08:09 EDT
成交量：774.98萬
成交額：1,387.98萬
市值：6.14億
市盈率：-2.73
高：1.84
開：1.78
低：1.77
收：1.78
52周最高：4.46
52周最低：1.04
股本：3.45億
流通股本：2.62億
量比：1.36
換手率：2.96%
股息：- -
股息率：- -
每股收益(TTM):-0.6510
每股收益(LYR):-0.8652
淨資產收益率：-42.39%
總資產收益率：-22.08%
市淨率：1.41
市盈率(LYR):-2.06

資料載入中...

總覽公司新聞資訊公告
2021/02/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/15

重要事件披露

8-K - Current report
2020/12/07

重要事件披露

8-K - Current report
2020/11/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

重要事件披露

8-K - Current report
2020/10/26

重要事件披露

8-K/A [Amend] - Current report
2020/08/10

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/05

重要事件披露

8-K - Current report
2020/07/10

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/11

重要事件披露

8-K - Current report
2020/06/04

重要事件披露

8-K - Current report
2020/05/29

重要事件披露

8-K - Current report
2020/05/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
更多